Fig. 2

Receiver operator characteristics (ROC) curves of peak hs-cTnT concentrations and a combined biomarker model. Combination of biomarkers did not result in significantly higher prognostic value for the prediction of MVO compared to hs-cTnT alone (AUC = 0.79, 95% CI 0.71–0.87 vs AUC = 0.77, 95% CI 0.68–0.85; p = 0.349). hs-cTnT = High-Sensitivity Cardiac Troponin T; CK = Creatine Kinase; NT-proBNP = N-terminal pro-B-type natriuretic peptide; hs-CRP = High-Sensitivity C-Reactive Protein; LDH = Lactate Dehydrogenase; AST = Aspartate Transaminase; ALT = Alanine Transaminase